Design and Synthesis of Novel 5-Acetylthiomethyl Oxazolidinone Analogs

REFERENCES

• Emori , T. G. ; Gaynes , R. P. An overview of nosocomial infections, including the role of the microbiology laboratory . Clin. Microbiol. Rev. 1993 , 6 , 428 – 442 .
   PubMed Web of Science ®Google Scholar
• Jones , R. N. Resistance patterns among nosocomial pathogens: Trends over the past few years . Chest 2001 , 119 , 397S – 404S .
   PubMed Web of Science ®Google Scholar
• Nicolau , D. Clinical and economic implications of antimicrobial resistance for the management of community-acquired respiratory tract infections . J. Antimicrob. Chemother. 2002 , 50 , 61 – 70 .
   PubMed Web of Science ®Google Scholar
• Pfefferkorn , J. A. ; Larsen , S. D. ; Huis , C. V. ; Sorenson , R. ; Barton , T. ; Winters , T. ; Auerbach , B. ; Wu , C. ; Wolfram , T. J. ; Cai , H. ; Welch , K. ; Esmaiel , N. ; Davis , J. ; Bousley , R. ; Olsen , K. ; Mueller , S. B. ; Mertz , T. Substituted oxazolidinones as novel NPC1L1 ligands for the inhibition of cholesterol absorption . Bioorg. Med. Chem. Lett. 2008 , 18 , 546 – 553 .
   PubMedGoogle Scholar
• Means , J. A. ; Katz , S. ; Nayek , A. ; Anupam , R. ; Hines , J. V. ; Bergmeier , S. C. Structure–activity studies of oxazolidinone analogs as RNA-binding agents . Bioorg. Med. Chem. Lett. 2006 , 16 , 3600 – 3604 .
   PubMed Web of Science ®Google Scholar
• Bergmeier , S. C. ; Katz , S. J. A method for the parallel synthesis of multiply substituted oxazolidinones . J. Comb. Chem. 2002 , 4 , 162 – 166 .
   PubMedGoogle Scholar
• Gregory , W. A. ; Brittelli , D. R. ; Wang , C. L. J. ; Kezar , H. S. ; Carlson , R. K. ; Park , C. H. ; Corless , P. F. ; Miller , S. J. ; Rajagopalan , P. ; Wuonola , M. A. ; McRipley , R. J. ; Eberly , V. S. ; See , A. M. ; Forbes , M. Antibacterials: Synthesis and structure–activity studies of 3-aryl-2-oxooxazolidines, 2: The “A” group . J. Med. Chem. 1990 , 33 , 2569 – 2578 .
   PubMedGoogle Scholar
• Reck , F. ; Zhou , F. ; Eyermann , C. J. ; Kern , G. ; Carcanague , D. ; Ioannidis , G. ; Illingworth , R. ; Poon , G. ; Gravestock , M. B. Novel substituted (pyridin-3-yl)phenyloxazolidinones: Antibacterial agents with reduced activity against monoamine oxidase a and increased solubility. J. Med. Chem. 2007, 50, 4868–4881.
   PubMed Web of Science ®Google Scholar
• Alice , H. L. ; Robert , W. M. ; Thomas , J. V. ; Keith , R. M. The oxazolidinone eperezolid binds to the 50S ribosomal subunit and competes with binding of chloramphenicol and lincomycin . Antimicrob. Agents Chemother. 1997 , 41 , 2127 – 2131 .
   PubMedGoogle Scholar
• Steve , M. S. ; Hiroyuki , A. ; Clelia , M. G. ; Dean , L. S. The oxazolidinone linezolid inhibits initiation of protein synthesis in bacteria . Antimicrob. Agents Chemother. 1998 , 42 , 3251 – 3255 .
   PubMedGoogle Scholar
• Alan , H. M. ; Douglas , J. B. ; John , D. T. ; Ronald , N. J. Spectrum and potency evaluation of a new oxazolidinone, linezolid: Report from the SENTRY Antimicrobial Surveillance Program, 1998–2000 . Diagnostic Microbiol. Infect. Dis. 2002 , 43 , 65 – 73 .
   PubMedGoogle Scholar
• Sattigeri , V. J. ; Soni , A. ; Singhal , S. ; Khan , S. ; Pandya , M. ; Bhatejab , B. ; Tarun Mathur , P. ; Rattan , A. ; Khanna , J. M. ; Mehta , A. Synthesis and antimicrobial activity of novel thiazolidinones . Arkivoc 2005 , 2 , 46 – 59 .
   Web of Science ®Google Scholar
• Wang , C. L. J. ; Gregory , W. A. ; Wuonola , M. A. Chlral synthesis of dup 721, a new antibacterial agent . Tetrahedron 1989 , 45 , 1323 – 1326 .
   Web of Science ®Google Scholar
• Ronald , D. G. ; Paul , C. S. ; Mary , B. G. ; Swathi , K. ; Karen , D. ; John , P. Q. Infections due to vancomycin-resistant enterococcus faecium resistant to linezolid . Lancet 2001 , 357 , 1179 .
   PubMedGoogle Scholar
• Johnson , A. P. ; Tysall , L. ; Stockdale , M. W. ; Woodford , N. ; Kaufmann , M. E. ; Warner , M. ; Livermore , D. M. ; Asboth , F. ; Allerberger , F. J. Emerging linezolid-resistant Enterococcus faecalis and Enterococcus faecium isolated from two Austrian patients in the same intensive care unit . Eur. J. Clin. Microbiol. Infect. Dis. 2002 , 21 , 751 – 754 .
   PubMed Web of Science ®Google Scholar
• Ryukou , T. ; Yoshiei , T. ; Yayoi , T. ; Tomio , S. ; Toshihiko , Y. ; Nobuhiko , I. ; Noriyuki , K. ; Eiichi , O. ; Osamu , N. Structure–activity relationship (SAR) studies on oxazolidinone antibacterial agents, 1: Conversion of 5-substituent on oxazolidinone . Chem. Pharm. Bull. 2001 , 49 , 347 – 352 .
   PubMedGoogle Scholar
• Ryukou , T. ; Yoshiei , T. ; Yayoi , T. ; Masatoshi , T. ; Toshihiko , Y. ; Nobuhiko , I. ; Noriyuki , K. ; Eiichi , O. ; Osamu , N. Structure–activity relationship (SAR) studies on oxazolidinone antibacterial agents, 2: Relationship between lipophilicity and antibacterial activity in 5-thiocarbonyl oxazolidinones . Chem. Pharm. Bull. 2001 , 49 , 353 – 360 .
   PubMedGoogle Scholar
• Ryukou , T. ; Yoshiei , T. ; Yayoi , T. ; Masatoshi , T. ; Nobuhiko , I. ; Noriyuki , K. ; Eiichi , O. ; Osamu , N. Structure–activity relationship (SAR) studies on oxazolidinone antibacterial agents, 3: Synthesis and evaluation of 5-thiocarbamate oxazolidinones . Chem. Pharm. Bull. 2001 , 49 , 361 – 367 .
   PubMedGoogle Scholar
• Braj , B. L. ; Vidya , B. L. ; Brijesh , K. S. ; Prashant , B. K. ; Purvi , P. Novel tetrahydro-thienopyridyl oxazolidinone: An antibacterial agent . Bioorg. Med. Chem. 2004 , 12 , 4557 – 4564 .
   PubMedGoogle Scholar
• Shingo , Y. ; Kazuo , O. ; Masakazu , F. Thiazolidine derivative and pharmaceutical composition containing the same. PCT Int. Appl. 9422857, 13 Oct. 1994 .
   Google Scholar
• Genim , M. J. ; Allwine , D. A. ; Anderson , D. J. ; Barbachyn , M. R. ; Emmert , D. E. ; Garmon , S. A. ; Graber , D. R. ; Grega , K. C. ; Hester , J. B. ; Hutchinson , D. K. ; Morris , J. ; Reischer , R. J. ; Ford , C. W. ; Zurenko , G. E. ; Hamel , J. C. ; Schaadt , R. D. ; Stapert , D. ; Yagi , B. H. Substituent effects on the antibacterial activity of nitrogen-carbon-linked (azolylphenyl) oxazolidinones with expanded activity against the fastidious Gram-negative organisms Haemophilus influenzae and Moraxella catarrhalis . J. Med. Chem. 2000 , 43 , 953 – 970 .
   PubMedGoogle Scholar
• Keshav , D. P. ; Dattatraya , S. M. ; Shriram , P. M. ; Dattatrya , Y. R. ; Vinayak , G. S. ; Yati , C. ; Nitin , S. ; Subhash , B. S. ; John , D. S. N. ; Vithalbhai , P. M. Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy. PCT Int. Appl. 2005054234, 16 Jun. 2005.
   Google Scholar
• Yasumichi , F. Cyclopropyl group substituted oxazolidinone antibiotics and derivatives thereof. PCT Int. Appl. 2005005398, 20 Jan. 2005 .
   Google Scholar
• Keol , R. J. ; Bin , I. W. ; Hwang , C. C. ; Hak , C. S. ; Ho , L. T. Novel oxazolidinone derivatives. PCT Int. Appl. 2005058886, 30 Jun. 2005 .
   Google Scholar
• Gregory , W. A. ; Brittelli , D. R. ; Wang , C. L. J. ; Wuonola , M. A. ; McRipley , R. J. ; Eustice , D. C. ; Eberly , V. S. ; Bartholomew , P. T. ; Slee , A. M. ; Forbes , M. Antibacterials: Synthesis and structure–activity studies of 3-aryl-2-oxooxazoliding, 1: The “B” group . J. Med. Chem. 1989 , 32 , 1673 – 1681 .
   PubMed Web of Science ®Google Scholar
• Brickner , S. J. ; Hutchinson , D. K. ; Barbachyn , M. ; Manninen , R. P. R. ; Ulanowicz , D. A. ; Garmon , S. A. ; Grega , K. C. ; Hendges , S. K. ; Toops , D. S. ; Ford , C. W. ; Zurenko , G. E. Synthesis and antibacterial activity of U-100592 and U-100766, two oxazolidinone antibacterial agents for the potential treatment of multidrug-resistant Gram-positive bacterial infections . J. Med. Chem. 1996 , 39 , 673 – 679 .
   PubMed Web of Science ®Google Scholar